195 related articles for article (PubMed ID: 34769307)
1. Tofacitinib Ameliorates Retinal Vascular Leakage in a Murine Model of Diabetic Retinopathy with Type 2 Diabetes.
Byrne EM; Llorián-Salvador M; Lyons TJ; Chen M; Xu H
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769307
[TBL] [Abstract][Full Text] [Related]
2. IL-17A Damages the Blood-Retinal Barrier through Activating the Janus Kinase 1 Pathway.
Byrne EM; Llorián-Salvador M; Tang M; Margariti A; Chen M; Xu H
Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356895
[TBL] [Abstract][Full Text] [Related]
3. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
6. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
7. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.
Li J; Wang JJ; Chen D; Mott R; Yu Q; Ma JX; Zhang SX
Exp Eye Res; 2009 Jun; 89(1):71-8. PubMed ID: 19254713
[TBL] [Abstract][Full Text] [Related]
9. Role of the JAK/STAT pathway in a streptozotocin-induced diabetic retinopathy mouse model.
Cho CH; Roh KH; Lim NY; Park SJ; Park S; Kim HW
Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3553-3563. PubMed ID: 35599279
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the hippocampal and hypothalamic blood-brain barrier in a diet-induced obese model of type II diabetes: prevention and treatment by the mitochondrial carbonic anhydrase inhibitor, topiramate.
Salameh TS; Mortell WG; Logsdon AF; Butterfield DA; Banks WA
Fluids Barriers CNS; 2019 Jan; 16(1):1. PubMed ID: 30616618
[TBL] [Abstract][Full Text] [Related]
11. IL-10-induced modulation of macrophage polarization suppresses outer-blood-retinal barrier disruption in the streptozotocin-induced early diabetic retinopathy mouse model.
Lee SJ; Noh SE; Jo DH; Cho CS; Park KS; Kim JH
FASEB J; 2024 May; 38(9):e23638. PubMed ID: 38713098
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Jun HO; Yu YS; Kim KW
Am J Pathol; 2010 Mar; 176(3):1517-24. PubMed ID: 20110406
[TBL] [Abstract][Full Text] [Related]
13. A potential novel therapeutic target in diabetic retinopathy: a chemokine receptor (CCR2/CCR5) inhibitor reduces retinal vascular leakage in an animal model.
Monickaraj F; Oruganti SR; McGuire P; Das A
Graefes Arch Clin Exp Ophthalmol; 2021 Jan; 259(1):93-100. PubMed ID: 32816099
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy.
Wang L; Wang N; Tan HY; Zhang Y; Feng Y
J Ethnopharmacol; 2015 Jul; 169():295-304. PubMed ID: 25929449
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
16. Effect of ruboxistaurin on blood-retinal barrier permeability in relation to severity of leakage in diabetic macular edema.
Strøm C; Sander B; Klemp K; Aiello LP; Lund-Andersen H; Larsen M
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3855-8. PubMed ID: 16186374
[TBL] [Abstract][Full Text] [Related]
17. Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice.
Kim J; Kim CS; Lee IS; Lee YM; Sohn E; Jo K; Kim JH; Kim JS
Endocrine; 2014 Aug; 46(3):462-9. PubMed ID: 24287793
[TBL] [Abstract][Full Text] [Related]
18. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
Mei X; Zhang T; Ouyang H; Lu B; Wang Z; Ji L
Biochem Pharmacol; 2019 Jan; 159():82-95. PubMed ID: 30447218
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
20. NAP modulates hyperglycemic-inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage.
D'Amico AG; Maugeri G; Rasà D; Federico C; Saccone S; Lazzara F; Fidilio A; Drago F; Bucolo C; D'Agata V
J Cell Physiol; 2019 Apr; 234(4):5230-5240. PubMed ID: 30374973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
